another bio company with dual listing is gtg
yesterday they released a credentialing update & gtg increased from 8.3c to 8.6c
last night nasdaq listed gene liked the update a lot more up 65.57% from $2.41 to finish @ $3.99 with an increase of x50 of volume
today gtg is up 40%
whats this got to with prr??
what may happen in the next year with phase 2b updates , dubai updates etc etc????
advantage of nasdaq listing
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $465.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 31.8¢ | $845.3K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 140318 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 14222 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |